The Global NGS Based Molecular Diagnostic Market is expected to grow at a compound annual growth rate of 6.35% in the forecast period of 2021 to 2028 and is expected to reach USD 2,823.16 million by 2028. The rising prevalence of infectious diseases and cancer and rising expenditure for the development of healthcare infrastructure are the significant factor bolstering the market growth rate.
Likewise, technological advancements and product innovations extends profitable will produce lucrative opportunities for the growth of the market.
NGS Based Molecular Diagnostic Market Scenario
According to Data Bridge Market Research the market for NGS based molecular diagnostic is expected to accelerate the market’s growth owing to the rising advancements in genomics and proteomics. Moreover, the increased focus on research and development activities to introduce advancements in molecular techniques, novel drugs and therapeutics is also expected to fuel the demand of the NGS based molecular diagnostic market over the forecast period of 2021 to 2028. The rising expenditure for research and development activities for molecular diagnostics and increasing application of NGS based molecular diagnostic against cancer also boost the market’s growth. On the other hand, the dearth of skilled or trained healthcare professionals is projected to challenge the NGS based molecular diagnostic market in the forecast period of 2021-2028.
Now the question is which are the other regions that NGS based molecular diagnostic market is targeting? Data Bridge Market Research has estimated large growth in Asia-Pacific due to the rising prevalence of cancer and infectious diseases within this region.
For more analysis on the NGS based molecular diagnostic request for a briefing with our analysts, https://www.databridgemarketresearch.com/de/speak-to-analyst/?dbmr=global-ngs-based-molecular-diagnostic-market
NGS Based Molecular Diagnostic Market Scope
NGS based molecular diagnostic market is segmented on the basis of countries into the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
- All country based analysis of NGS based molecular diagnostic market is further analyzed based on maximum granularity into further segmentation. On the basis of application, the NGS based molecular diagnostic market is classified into microbiology, infectious diseases, oncology, genetic tests and other applications. On the basis of end users, the NGS based molecular diagnostic market is bifurcated into research centers and academics, hospitals and clinical laboratories and others.
- Next-generation sequencing-based molecular diagnostics (NGS) is a low-cost medical treatment that uses micro and nanotechnologies to fight a variety of infectious diseases. It uses massive parallel sequencing to perform a large number of sequences in a short amount of time. Molecular diagnostics is the study of proteins and nucleic acids at the molecular level.
To know more about the study, https://www.databridgemarketresearch.com/de/reports/global-ngs-based-molecular-diagnostic-market
Key Pointers Covered in the NGS Based Molecular Diagnostic Market Industry Trends and Forecast to 2028
- Market Size
- Market New Sales Volumes
- Market Replacement Sales Volumes
- Market Installed Base
- Market By Brands
- Market Procedure Volumes
- Market Product Price Analysis
- Market Healthcare Outcomes
- Market Cost of Care Analysis
- Market Regulatory Framework and Changes
- Prices and Reimbursement Analysis
- Market Shares in Different Regions
- Recent Developments for Market Competitors
- Market Upcoming Applications
- Market Innovators Study
Key Market Competitors Covered in the Report
- Novartis AG
- BD
- Abbott
- Danaher
- Thermo Fisher Scientific Inc
- bioMérieux SA
- Biomerica, Inc
- F. Hoffmann-La Roche Ltd
- Siemens AG
- Johnson & Johnson Services, Inc
- Carestream Health
- FUJIFILM Holdings Corporation
- Hologic, Inc
- Bio-Rad Laboratories, Inc
- Bayer AG
- Agilent Technologies, Inc
- Illumina, Inc
- DiaSorin S.p.A
- Grifols, S.A.
- Sysmex Corporation
Above are the key players covered in the report, to know about more and exhaustive list of NGS based molecular diagnostic companies’ contact us, https://www.databridgemarketresearch.com/de/toc/?dbmr=global-ngs-based-molecular-diagnostic-market
Research Methodology of Global NGS Based Molecular Diagnostic Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Related Reports
- Global Molecular Diagnostics Market - Industry Trends and Forecast to 2028
- Global Point of Care Molecular Diagnostics Market - Industry Trends and Forecast to 2028
- Global Hybridization-based Molecular Diagnostics Market - Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/de/report-category/healthcare/
